Alyeska Investment Group’s ACELYRIN SLRN Stock Holding History

Alyeska Investment Group’s Portfolio SLRN Stock Details SLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-615,878	Closed	-$1.52M	–	662
2025 Q1	$1.52M	Sell	615,878 -900,000	-59%	-$2.14M	0.01%	425
2024 Q4	$4.76M	Buy	+1,515,878	New	+$7.34M	0.02%	402
2024 Q1	–	Sell	-50,070	Closed	-$374K	–	602
2023 Q4	$374K	Hold	50,070	–	–	﹤0.01%	450
2023 Q3	$509K	Hold	50,070	–	–	﹤0.01%	450
2023 Q2	$1.05M	Buy	+50,070	New	+$1.02M	0.01%	450

Other funds holding SLRN

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Alyeska Investment Group's SLRN Position: Q2 2025 in Review

Alyeska Investment Group sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 615,878 shares — an estimated $1.52M sold.

Alyeska Investment Group first reported a position in SLRN in Q2 2023 and held it in 5 quarters. The position peaked at $4.76M in Q4 2024. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.

Alyeska Investment Group reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
Alyeska Investment Group sold 615,878 ACELYRIN shares in Q2 2025, an estimated $1.52M.
Alyeska Investment Group first reported a position in ACELYRIN in Q2 2023 and held it in 5 quarters.
Alyeska Investment Group's ACELYRIN position peaked at $4.76M in Q4 2024.
2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.

Based on Alyeska Investment Group's 13F filing for Q2 2025, filed 14 Aug 2025.